THE TMPRSS2:ERG REARRANGEMENT, ERG EXPRESSION, AND PROSTATE CANCER OUTCOMES: A COHORT STUDY AND META-ANALYSIS

BACKGROUND: Whether the genomic rearrangement TMPRSS2:ERG has prognostic value in prostate cancer is unclear. METHODS: Among men with prostate cancer in the prospective Physicians’ Health and Health Professionals Follow-Up Studies, we identified rearrangement status by immunohistochemical assessment...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Pettersson, Andreas, Graff, Rebecca E., Bauer, Scott R., Pitt, Michael, Lis, Rosina T., Stack, Edward C., Martin, Neil E., Kunz, Lauren, Penney, Kathryn L., Ligon, Azra H., Suppan, Catherine, Flavin, Richard, Sesso, Howard D., Rider, Jennifer R., Sweeney, Christopher, Stampfer, Meir, Fiorentino, Michelangelo, Kantoff, Philip W., Sanda, Martin, Giovannucci, Edward, Ding, Eric L., Loda, Massimo, Mucci, Lorelei A.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2012
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671609/
https://ncbi.nlm.nih.gov/pubmed/22736790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-12-0042
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים